Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis Effects on ART PK and Neurotoxicity
NCT04800159Phase 2Active, not recruiting
- Sponsor
- University of California, San Diego
- Start
- Feb 2021
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabis in human immunodeficiency virus infection (HIV), sponsored by University of California, San Diego. Started Feb 2021; status: active, not recruiting.
02
Drugs
cannabis
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04800159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04800159.